Charles E de Bock
28PUBLICATIONS
106CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (28)
Sort by Publication Date:
|Jan 21, 2025
TLE4 is a repressor of the oncogenic activity of TLX3 in T-cell acute lymphoblastic leukemia.Lukas Lauwereins, Quentin Van Thillo, Sofie Demeyer
|Nov 08, 2024
PU.1 eviction at lymphocyte-specific chromatin domains mediates glucocorticoid response in acute lymphoblastic leukemia.Dominik Beck, Honghui Cao, Feng Tian
|Nov 06, 2024
The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemia.Cara E Toscan, Hannah McCalmont, Amir Ashoorzadeh
|Dec 29, 2023
The landscape of alterations affecting epigenetic regulators in T-cell acute lymphoblastic leukemia: Roles in leukemogenesis and therapeutic opportunities.Yashna Walia, Charles E de Bock, Yizhou Huang
|May 17, 2023
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia.Ernest Moles, Christopher B Howard, Pie Huda
Pageof 5
Frequent Collaborators
8 joint publications
Jan Cools
7 joint publications
Hansen Kosasih
4 joint publications
Matthew D Dun
3 joint publications
Nicole M Verrills
3 joint publications
Yizhou Huang
2 joint publications
Chelsea Mayoh
2 joint publications
David A Skerrett-Byrne
2 joint publications
Ernest Moles
2 joint publications
Quentin Van Thillo
2 joint publications
Geoff De Iuliis